Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv41-iv50. doi: 10.1093/annonc/mdy146.

Authors

E Kastritis¹, V Leblond², M A Dimopoulos¹, E Kimby³, P Staber⁴, M J Kersten^{5

6}, A Tedeschi⁷, C Buske⁸; ESMO Guidelines Committee

Affiliations

¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Hematology, Pitié Salpêtrière Hospital, Pierre and Marie Curie University, UPMC GRC11-GRECHY, Paris, France.
³ Division of Hematology, Department of Medicine at Huddinge, Karolinska Institute and University Hospital, Stockholm, Sweden.
⁴ Division of Hematology and Hemostaseology, Department of Internal Medicine I, Vienna General Hospital, Vienna, Austria.
⁵ Department of Hematology, Academic Medical Center.
⁶ LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
⁷ Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
⁸ Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.

PMID: 29982402
DOI: 10.1093/annonc/mdy146

No abstract available

Publication types

Practice Guideline

MeSH terms

Aftercare / methods
Aftercare / standards
Age of Onset
Antineoplastic Combined Chemotherapy Protocols / standards
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Asymptomatic Diseases / therapy
Bone Marrow / pathology
Europe
Humans
Incidence
Medical Oncology / methods
Medical Oncology / standards*
Myeloid Differentiation Factor 88 / genetics
Neoplasm Recurrence, Local / diagnosis
Neoplasm Recurrence, Local / epidemiology
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / therapy*
Neoplasm Staging
Plasmapheresis / methods
Plasmapheresis / standards
Precision Medicine / methods
Precision Medicine / standards*
Receptors, CXCR4 / genetics
Societies, Medical / standards*
Stem Cell Transplantation / methods
Stem Cell Transplantation / standards
Survivorship
Transplantation, Autologous / methods
Transplantation, Autologous / standards
Treatment Outcome
Waldenstrom Macroglobulinemia / diagnosis
Waldenstrom Macroglobulinemia / epidemiology
Waldenstrom Macroglobulinemia / pathology
Waldenstrom Macroglobulinemia / therapy*

Substances

CXCR4 protein, human
MYD88 protein, human
Myeloid Differentiation Factor 88
Receptors, CXCR4